Vladimir Konstantinovich Lepakhin (The 75th birthday)

by Editorial Article
Published 2018-02-01

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4

by T. V. Romanova, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, I. I. Snegireva, M. A. Darmostukova, D. A. Kaperko, N. Yu. Velts, A. S. Kazakov, E. V. Shubnikova, R. N. Alyautdin
Published 2018-06-01

Drug Safety Monitoring Information

by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina
Published 2021-07-01

Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin

by A. A. Kachanova, Yu. A. Pimenova, G. N. Shuev, K. A. Akmalova, Zh. A. Sozaeva, N. M. Krasnova, E. A. Grishina, D. A. Sychev
Published 2021-03-01

Safety of Use of Russian Biosimilars of Interferon Beta-1b in the Treatment of Multiple Sclerosis: a Meta-analysis of Original Studies

by D. O. Gudz, A. E. Krasnov, R. N. Mamleev, R. K. Kagirov, M. L. Maximov
Published 2019-06-01

Assessment of Pharmacovigilance Reporting in Russia

by Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. E. Krasheninnikov, E. V. Shubnikova
Published 2018-12-01

Drug Safety for Children — International Monitoring Data for 50 Years

by B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, G. O. Dibirova, N. B. Dmitrieva, I. B. Zhukova, E. V. Kalinina, A. V. Kirillova, N. M. Kiseleva, G. V. Kukushkin, T. I. Leonteva, M. L. Maximov, E. V. Markina, S. E. Mileshina, D. E. Yurov
Published 2019-06-01

Drug-Induced Fatty Liver Disease

by A. P. Pereverzev, O. D. Ostroumova
Published 2020-06-01

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents

by E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko, G. V. Kutekhova
Published 2020-03-01

Safety of Herbal Medicines: Clinical and Pharmacological Aspects

by O. A. Demidova, V. V. Arkhipov, M. V. Zhuravleva, T. A. Alexandrova, A. A. Alexandrov
Published 2020-12-01

Learning Needs as a Reflection of Professional Interests among Health Experts

by N. G. Goloenko, R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, M. V. Protsenko, P. A. Logvinyuc
Published 2019-03-01

Non-pharmacological Approaches to Treatment of Patients over 60 Years as a Way to Improve Pharmacotherapy Safety and Prevent Polypharmacy

by A. P. Pereverzev, O. N. Tkacheva, Yu. V. Kotovskaya, Yu. S. Onuchina, E. N. Dudinskaya, A. V. Naumov
Published 2018-12-01

Ongoing challenges and future directions of human papillomavirus vaccination

by O. S. Alyautdina, V. Yu. Prilutskaya
Published 2020-09-01

INFORMATION FOR AUTHORS

by article editorial
Published 2018-06-01

Some Aspects of Drug Induced Nephrotoxicity Assessment

by E. A. Sokova, V. V. Arkhipov, I. A. Mazerkina, O. V. Muslimova
Published 2020-09-01

ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS

by A. R. Titova, E. Y. Pasternak, I. L. Asetskaya, S. K. Zyryanov, V. A. Polivanov, R. N. Alyautdin, B. K. Romanov
Published 2018-02-01

SGLT2 inhibitors: control of glycemia and nephroprotection properties

by A. A. Volodin, M. L. Maximov, V. G. Slobodyan, R. N. Alyautdin
Published 2018-02-01

Identification and assessment of cases of malignant hyperthermia triggering under anaesthetic management: analysis of spontaneous reporting database

by E. Yu. Kolesnikova, E. O. Zhuravleva, I. L. Asetskaya, K. E. Zatolochina
Published 2018-02-01

Coronavirus disease COVID-2019

by B. K. Romanov
Published 2020-03-01

Applied Research Conference “Current Approaches to Evaluation of Medicinal Products” (RegLek 2020)

by article Editorial
Published 2020-12-01